Jonathan Howlett

Clinical Professor

University of Calgary Cumming School of Medicine

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jonathan Howlett is a Clinical Professor at the Cumming School of Medicine, University of Calgary, Canada. His research areas focus on heart failure, including the use of SGLT2 inhibitors, hematopoietic cell transplantation for systemic sclerosis, and the integration of endomyocardial biopsy into clinical practice. Recent publications include analyses of treatment efficacy in heart failure and the role of dietary sodium reduction in managing the condition.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Matthew Woo

University of Calgary

CANADA

View details

David Ian Paterson

Professor

University of Ottawa Heart Institute

CANADA

View details

Kerri Johannson

Associate Professor

University of Calgary

CANADA

View details

Jawad H Butt

DENMARK

View details

MODELE OGUNNIYI

Emory University

UNITED STATES

View details

Jason Weatherald

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jonathan Howlett

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Is It Time to Relitigate SGLT2 Inhibitor Dose for Heart Failure?

Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review

The International Endomyocardial Biopsy Position Paper: A Basis for Integration Into Modern Clinical Practice

Assessment of Omecamtiv Mecarbil for the Treatment of Patients with Severe Heart Failure: A Post Hoc Analysis of Data from the GALACTIC-HF Randomized Clinical Trial

Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk

Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial

Cardiac remodelling predicts outcome in patients with chronic heart failure

Cautious optimism for machine learning techniques for prediction of heart failure outcomes

Collaborators (6)

Matthew Woo

David Ian Paterson

Kerri Johannson

Jawad H Butt

MODELE OGUNNIYI

Jason Weatherald

Make your next move.